Headshot of Jeffrey Samet
Profiles

Jeffrey H Samet, MD, MA, MPH

Professor, Community Health Sciences - Boston University School of Public Health

(617) 414-7444
jeff.samet@bmc.org
Crosstown Center
View Full Profile at BUMC

Biography

My research has focused on alcohol and drug use, HIV infection and primary medical care with the following specific projects: linkage of alcohol and drug use treatment and primary medical care; addressing alcohol and drug use issues in the primary care setting; the impact of alcohol and drug use in HIV-infected persons; HIV prevention and treatment in Russian substance users; and establishing medical care for HIV-infected persons.

Other Positions

  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University
  • Faculty, Medicine - Boston University Chobanian & Avedisian School of Medicine

Education

  • Baylor College of Medicine, MD Field of Study: Medicine
  • Boston University, MPH Field of Study: Epidemiology
  • Brandeis University, MA Field of Study: Chemistry
  • Brandeis University, BA

Websites

Publications

  • Published on 2/11/2025

    Fuster D, So-Armah K, Cheng DM, Blokhina E, Patts G, Lioznov D, Gnatienko N, Long MT, Freiberg MS, Tindle H, Samet JH. Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV? J Clin Med. 2025 Feb 11; 14(4). PMID: 40004700.

     Read At: PubMed
  • Published on 1/29/2025

    Bhatraju EP, Kennedy DN, Gojic AJ, Iles-Shih M, Merrill JO, Samet JH, Hallgren KA, Tsui JI. mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder. Addict Sci Clin Pract. 2025 Jan 29; 20(1):6. PMID: 39881397.

     Read At: PubMed
  • Published on 12/4/2024

    Lewis N, Eggleston B, Chandler RK, Goddard-Eckrich D, Luster JE, Beard DD, Rodgers E, Chahine R, Westgate PM, Benjamin SN, Holloway J, Clarke T, Lefebvre RC, Stein MD, Helme DW, Reynolds J, Walsh SL, Freedman D, El-Bassel N, Stephens K, Silwal A, Lofwall M, Childerhose JE, Surratt HL, Crockett BN, Farmer AL, David JL, Fanucchi L, Harness J, Wilburn B, Bursey K, Mattson K, Mann S, Jackson RD, Shadwick A, Calver K, Chassler D, Kimball J, Regan N, Samet JH, Sword-Cruz R, Slater MD. Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention. PLoS One. 2024; 19(12):e0308965. PMID: 39630633.

     Read At: PubMed
  • Published on 11/10/2024

    Weinstein ZM, Yu O, Wartko PD, Samet JH, Bobb JF, Braciszewski JM, Arnsten JH, Murphy MT, Horigian VE, Stotts AL, Beers D, Bradley K. Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial. Drug Alcohol Depend. 2024 Dec 01; 265:112497. PMID: 39550823.

     Read At: PubMed
  • Published on 11/7/2024

    Lunze K, Carroll JJ, Ahuja N, Lira MC, Tsui JI, Ventura A, Colasanti JA, Liebschutz JM, Del Rio C, Samet JH. Opioid risk-reduction strategies for people with HIV on chronic opioid therapy: A qualitative study of patient perspectives. SSM Ment Health. 2024 Dec; 6. PMID: 39990723.

     Read At: PubMed
  • Published on 11/4/2024

    Lapham GT, Hyun N, Bobb JF, Wartko PD, Matthews AG, Yu O, McCormack J, Lee AK, Liu DS, Samet JH, Zare-Mehrjerdi M, Braciszewski JM, Murphy MT, Arnsten JH, Horigian V, Caldeiro RM, Addis M, Bradley KA. Nurse Care Management of Opioid Use Disorder Treatment After 3 Years: A Secondary Analysis of the PROUD Cluster Randomized Clinical Trial. JAMA Netw Open. 2024 Nov 04; 7(11):e2447447. PMID: 39576637.

     Read At: PubMed
  • Published on 10/22/2024

    Y Bernstein E, Magane KM, Dukes KA, Palfai TP, Lee JH, Saitz R, Samet JH. Correlates of post-hospitalization naltrexone adherence for alcohol use disorder. Drug Alcohol Depend. 2024 Dec 01; 265:112470. PMID: 39461121.

     Read At: PubMed
  • Published on 10/17/2024

    Nadareishvili I, Rao SR, Otiashvili D, Gnatienko N, Samet JH, Lunze K, Kirtadze I. Post-legalization shifts in cannabis use among young adults in Georgia-A nationally representative study. Addiction. 2025 Feb; 120(2):335-346. PMID: 39417804.

     Read At: PubMed
  • Published on 10/10/2024

    Freeman PR, Walley AY, Winhusen TJ, Oga EA, Villani J, Hunt T, Chandler RK, Oyler DR, Reilly B, Gelberg K, Douglas C, Lyons MS, Holloway J, Vandergrift NA, Adams JW, Asman K, Baker TJ, Brancato CJ, Cheng DM, Childerhose JE, David JL, Feaster DJ, Gilbert L, Glasgow LM, Goddard-Eckrich DA, Knott C, Knudsen HK, Lofwall MR, Marks KR, McMullan JT, Oser CB, Roberts MF, Shoben AB, Stein MD, Walters ST, Watson J, Zarkin GA, Jackson RD, Samet JH, Walsh SL, Bassel NE. Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial. Am J Public Health. 2025 Jan; 115(1):83-94. PMID: 39388670.

     Read At: PubMed
  • Published on 10/1/2024

    Freisthler B, Chahine RA, Villani J, Chandler R, Feaster DJ, Slavova S, Defiore-Hyrmer J, Walley AY, Kosakowski S, Aldridge A, Barbosa C, Bhatta S, Brancato C, Bridden C, Christopher M, Clarke T, David J, D'Costa L, Ewing I, Fernandez S, Gibson E, Gilbert L, Hall ME, Hargrove S, Hunt T, Kinnard EN, Larochelle L, Macoubray A, Nigam S, Nunes EV, Oser CB, Pagnano S, Rock P, Salsberry P, Shadwick A, Stopka TJ, Tan S, Taylor JL, Westgate PM, Wu E, Zarkin GA, Walsh SL, El-Bassel N, Winhusen TJ, Samet JH, Oga EA. Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial. JAMA Netw Open. 2024 Oct 01; 7(10):e2440006. PMID: 39432308.

     Read At: PubMed

View 472 more publications:View Full Profile at BUMC

News & In the Media

View all profiles